Harris Martin reported that a U.S. district judge threw out a patient's lawsuit alleging that U.K. orthopedics giant Smith & Nephew's metal hip replacement left her in pain, disabled and needing replacement surgery.
Bloomberg reported that Intuitive Surgical has issued a recall affecting more than 1,300 robot arms of its da Vinci surgical around the world because they may be producing too much friction. When that happens, the da Vinci can choke during surgery and briefly stop working before it catches up.
Johnson & Johnson's executives preparing for upcoming trials alleging the company's Ethicon division sold faulty vaginal mesh that harmed legions of women are already facing a bombshell accusation: patients' attorneys accuse employees of destroying or losing hundreds of thousands of vital product documents.
A number of Philips automated external defibrillators may still be duds, potentially failing to deliver the shock needed in an emergency despite a recall initiated more than a year ago intended to address the issue, the FDA cautioned.
Insurers also stand to gain plenty from Johnson & Johnson's $2.5 billion-plus offer to settle 8,000 lawsuits involving faulty metal hip implants. Bloomberg reported that the conglomerate will fork over as much as $1 billion to insurers who covered patients' cost of removing the now-recalled ASR implants.
Johnson & Johnson's $2.5 billion-plus agreement to settle as many as 8,000 lawsuits over faulty metal hip implants made by its subsidiary, DePuy, is already getting pushback. Patients complain their attorneys and the company itself gain more than they do from the deal, and if discontent rises, it could place the overall agreement at risk.
Hospira's long-troubled infusion pump business is dealing with another recall, earning the FDA's most severe warning over a device malfunction the agency said can lead to serious injury and death.
Johnson & Johnson has confirmed an agreement to fork over at least $2.5 billion to settle thousands of lawsuits alleging injuries caused by defective all-metal hip implants. A large majority of eligible plaintiffs reportedly must support the agreement for it to go forward, and legions of legal cases not included in the deal will remain in play.
Medtronic began a month ago to recall a number of potentially faulty guidewires used for various cardiac procedures, and now the FDA has slapped the effort with its most-serious "Class I" label. At least one patient has been injured, the company said.
A Canadian patient is suing Biomet for damages, alleging it sold a malfunctioning and harmful metal-on-metal hip implant. The class-action lawsuit adds to the burden of hundreds of related U.S. court cases already in the pipeline against the Indiana company.